Literature DB >> 18497453

Higher serum free thyroxine levels are associated with coronary artery disease.

Chan-Hee Jung1, Eun-Jung Rhee, Hun-Sub Shin, Sook-Kyoung Jo, Jong-Chul Won, Cheol-Young Park, Byung-Jin Kim, Ki-Chul Sung, Bum-Soo Kim, Won-Young Lee, Ki-Won Oh, Jin-Ho Kang, Sung-Woo Park, Man-Ho Lee, Sun-Woo Kim.   

Abstract

Thyroid hormone has many effects on the heart and cardiovascular system. Thyrotoxicosis is associated with increased cardiovascular morbidity and mortality, primarily due to heart failure and thromboembolism. However, the relationship between thyroid hormone excess and the cardiac complications of angina pectoris and myocardial infarction remains largely speculative. Moreover, few studies have been reported on the effect of thyroid hormone levels within normal range on coronary artery disease (CAD). Therefore we examined the association of thyroid function with coronary artery diseases in euthyroid angina patients. Total 192 subjects (mean age; 60.8 yrs) were enrolled in which coronary angiograms were performed due to chest pain. We measured free thyroxine (FT(4)), thyroid stimulating hormone (TSH), serum lipid levels and high-sensitivity C-reactive protein (hsCRP) levels and analyzed their association with the presence of CAD. Serum FT(4) levels were higher in patients with CAD compared with the patients without CAD (1.31 +/- 0.30 vs 1.20 +/- 0.23, p = 0.006), and high FT(4) level was associated with the presence of multi-vessel disease. Multivariate analysis showed that age (odds ratio (OR) 1.04; 95% confidence interval (CI) 1.01-1.07, p = 0.007), hypertension (OR 2.04; 95% CI 1.06-3.90, p = 0.036) and FT(4) (OR 4.23; 95% CI 1.12-15.99, p = 0.033), were the determinants for CAD. The relative risk (RR) for CAD in highest tertile of FT(4) showed increased risk compared with the lowest tertile (RR 1.98; 95% CI 0.98-3.99, p<0.001). Our study showed that FT(4) levels were associated with the presence and the severity of CAD. Also, this study suggests that elevated serum FT(4) levels even within normal range could be a risk factor for CAD. Further studies will be necessary to confirm the relationship of thyroid function and CAD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18497453     DOI: 10.1507/endocrj.k08e-010

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  11 in total

1.  Normal thyroid-stimulating hormone levels, autoimmune activation, and coronary heart disease risk.

Authors:  Altan Onat; Mesut Aydın; Günay Can; Etem Çelik; Servet Altay; Ahmet Karagöz; Evin Ademoğlu
Journal:  Endocrine       Date:  2014-05-03       Impact factor: 3.633

2.  Association of Thyroid Function with Severity of Coronary Artery Disease in Euthyroid Patients.

Authors:  Ravi Daswani; B Jayaprakash; Ranjan Shetty; N R Rau
Journal:  J Clin Diagn Res       Date:  2015-06-01

3.  Thyroid stimulating hormone, independent of thyroid hormone, can elevate the serum total cholesterol level in patients with coronary heart disease: a cross-sectional design.

Authors:  Chao Xu; Xiaomei Yang; Wenhui Liu; Haitao Yuan; Chunxiao Yu; Ling Gao; Jiajun Zhao
Journal:  Nutr Metab (Lond)       Date:  2012-05-23       Impact factor: 4.169

4.  Hyperthyroidism-associated coronary spasm: A case of non-ST segment elevation myocardial infarction with thyrotoxicosis.

Authors:  Xiao-Hu Kuang; Shu-Yang Zhang
Journal:  J Geriatr Cardiol       Date:  2011-12       Impact factor: 3.327

5.  Relationship and prognostic importance of thyroid hormone and N-terminal pro-B-Type natriuretic peptide for patients after acute coronary syndromes: a longitudinal observational study.

Authors:  Julija Brozaitiene; Narseta Mickuviene; Aurelija Podlipskyte; Julius Burkauskas; Robertas Bunevicius
Journal:  BMC Cardiovasc Disord       Date:  2016-02-18       Impact factor: 2.298

6.  Free triiodothyronine in relation to coronary severity at different ages: Gensini score assessment in 4206 euthyroid patients.

Authors:  Bing-Yang Zhou; Yuan-Lin Guo; Na-Qiong Wu; Cheng-Gang Zhu; Ying Gao; Ping Qing; Xiao-Lin Li; Yao Wang; Geng Liu; Qian Dong; Jian-Jun Li
Journal:  J Geriatr Cardiol       Date:  2016-12       Impact factor: 3.327

7.  ECG changes in patients with primary hyperthyroidism.

Authors:  Ishtiaque Hussain Baladi; Ayesha Aslam Rai; Syed Masroor Ahmed
Journal:  Pan Afr Med J       Date:  2018-08-02

8.  Thyroid Function, Prevalent Coronary Heart Disease, and Severity of Coronary Atherosclerosis in Patients Undergoing Coronary Angiography.

Authors:  Yan Ling; Jingjing Jiang; Minghui Gui; Lin Liu; Qiqige Aleteng; Bingjie Wu; Shanshan Wang; Xiaojing Liu; Xin Gao
Journal:  Int J Endocrinol       Date:  2015-12-03       Impact factor: 3.257

9.  High-normal thyroid-stimulating hormone in euthyroid subjects is associated with risk of mortality and composite disease endpoint only in women.

Authors:  Servet Altay; Altan Onat; Günay Can; Eyyup Tusun; Barış Şimşek; Adnan Kaya
Journal:  Arch Med Sci       Date:  2016-10-26       Impact factor: 3.318

10.  Associations of Thyroid Hormone Levels and Macrovascular Complications in Euthyroid Type 2 Diabetic Patients.

Authors:  Yonghui Hu; Zhiyue Yan; Congqing Pan
Journal:  Diabetes Metab Syndr Obes       Date:  2021-06-15       Impact factor: 3.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.